Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 752

1.

How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.

Kunkel A, Colijn C, Lipsitch M, Cohen T.

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670). pii: 20140306. doi: 10.1098/rstb.2014.0306.

2.

The prospective evaluation of the TB strain typing service in England: a mixed methods study.

Mears J, Vynnycky E, Lord J, Borgdorff MW, Cohen T, Crisp D, Innes JA, Lilley M, Maguire H, McHugh TD, Woltmann G, Abubakar I, Sonnenberg P.

Thorax. 2015 Apr 16. pii: thoraxjnl-2014-206480. doi: 10.1136/thoraxjnl-2014-206480. [Epub ahead of print]

PMID:
25882538
3.
4.

Toxin-Induced Necroptosis Is a Major Mechanism of Staphylococcus aureus Lung Damage.

Kitur K, Parker D, Nieto P, Ahn DS, Cohen TS, Chung S, Wachtel S, Bueno S, Prince A.

PLoS Pathog. 2015 Apr 16;11(4):e1004820. doi: 10.1371/journal.ppat.1004820. eCollection 2015 Apr.

5.

Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.

Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T.

J R Soc Interface. 2015 May 6;12(106). pii: 20150146. doi: 10.1098/rsif.2015.0146.

6.

Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature.

Chen G, Zhao J, Cohen T, Tao C, Sun J, Xu H, Bernstam EV, Lawson A, Zeng J, Johnson AM, Holla V, Bailey AM, Lara-Guerra H, Litzenburger B, Meric-Bernstam F, Jim Zheng W.

Database (Oxford). 2015 Apr 8;2015. pii: bav034. doi: 10.1093/database/bav034. Print 2015.

7.

Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration.

Cohen TV, Kollias HD, Liu N, Ward CW, Wagner KR.

J Physiol. 2015 Apr 8. doi: 10.1113/JP270201. [Epub ahead of print]

PMID:
25854148
8.

Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions.

Tewksbury R, Taumoepeau L, Cartmill A, Butcher A, Cohen T.

Vascular. 2015 Mar 26. pii: 1708538114568479. [Epub ahead of print]

PMID:
25819513
9.

PCRA Revisited: Testing the Validity of the Federal Post Conviction Risk Assessment (PCRA).

Lowenkamp CT, Holsinger AM, Cohen TH.

Psychol Serv. 2015 Mar 23. [Epub ahead of print]

PMID:
25798662
10.

Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.

Shrestha S, Knight GM, Fofana M, Cohen T, White RG, Cobelens F, Dowdy DW.

Open Forum Infect Dis. 2014 Aug 30;1(2):ofu073. doi: 10.1093/ofid/ofu073. eCollection 2014 Sep.

11.

HDAC4 Regulates Muscle Fiber Type-Specific Gene Expression Programs.

Cohen TJ, Choi MC, Kapur M, Lira VA, Yan Z, Yao TP.

Mol Cells. 2015 Apr 30;38(4):343-8. doi: 10.14348/molcells.2015.2278. Epub 2015 Feb 25.

12.

Foot-to-foot bioelectrical impedance accurately tracks direction of adiposity change in overweight and obese 7- to 13-year-old children.

Kasvis P, Cohen TR, Loiselle SÈ, Kim N, Hazell TJ, Vanstone CA, Rodd C, Plourde H, Weiler HA.

Nutr Res. 2015 Mar;35(3):206-13. doi: 10.1016/j.nutres.2014.12.012. Epub 2015 Jan 7.

PMID:
25697463
13.

Origin and proliferation of multiple-drug resistance in bacterial pathogens.

Chang HH, Cohen T, Grad YH, Hanage WP, O'Brien TF, Lipsitch M.

Microbiol Mol Biol Rev. 2015 Mar;79(1):101-16. doi: 10.1128/MMBR.00039-14.

PMID:
25652543
14.
15.

Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.

Kwon JS, McAlpine JN, Hanley GE, Finlayson SJ, Cohen T, Miller DM, Gilks CB, Huntsman DG.

Obstet Gynecol. 2015 Feb;125(2):338-45. doi: 10.1097/AOG.0000000000000630.

PMID:
25568991
16.

An acetylation switch controls TDP-43 function and aggregation propensity.

Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM.

Nat Commun. 2015 Jan 5;6:5845. doi: 10.1038/ncomms6845.

17.

Magnitude and sources of bias in the detection of mixed strain M. tuberculosis infection.

Plazzotta G, Cohen T, Colijn C.

J Theor Biol. 2015 Mar 7;368:67-73. doi: 10.1016/j.jtbi.2014.12.009. Epub 2014 Dec 29.

18.

Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis.

Menzies NA, Cohen T, Murray M, Salomon JA.

Lancet Infect Dis. 2015 Jan;15(1):16-7. doi: 10.1016/S1473-3099(14)71026-6. No abstract available.

PMID:
25541164
19.

On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.

Cohen T, Jenkins HE, Lu C, McLaughlin M, Floyd K, Zignol M.

Drug Resist Updat. 2014 Oct-Dec;17(4-6):105-23. doi: 10.1016/j.drup.2014.10.001. Epub 2014 Oct 6.

20.

Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle.

J Gardner T, Cohen T, Redmann V, Lau Z, Felsenfeld D, Tortorella D.

Antiviral Res. 2015 Jan;113:49-61. doi: 10.1016/j.antiviral.2014.10.011. Epub 2014 Oct 31.

PMID:
25446405
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk